We are live on ! Find out more
IEIH

iShares Evolved U.S. Innovative Healthcare ETF
IEIH

Delisted

IEIH was delisted on the 22nd of August, 2022.

Back to rankings

5 hedge funds and large institutions have $2.26M invested in iShares Evolved U.S. Innovative Healthcare ETF in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 5 → 5 (0)

35.77% less ownership

Funds ownership: 82.47% → 46.7% (-36%)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

99% less capital inflows, than outflows

Capital inflows: $10.4K | Capital outflows: $1.79M

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
+$10.4K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.74M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$24.8K
3
Advisor Group
Advisor Group
Arizona
-$24K

IEIH Hedge Fund Activity: Q3 2019 in Review

5 of the 4,576 institutional investors tracked by Wall St. Rank reported a position in iShares Evolved U.S. Innovative Healthcare ETF (IEIH) for Q3 2019, worth a combined $2.26M — down 46% from $4.21M a quarter earlier.

Fund positioning in IEIH was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 3 trimmed.

The largest buyer was Tower Research Capital (TRC), adding an estimated $10.4K. The largest seller was BlackRock, cutting an estimated $1.74M.

  • 5 institutional investors held iShares Evolved U.S. Innovative Healthcare ETF (IEIH) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $2.26M of iShares Evolved U.S. Innovative Healthcare ETF stock for Q3 2019, down 46% quarter-over-quarter.
  • 0 funds opened new iShares Evolved U.S. Innovative Healthcare ETF positions in Q3 2019 and 0 closed out.
  • The largest iShares Evolved U.S. Innovative Healthcare ETF buyer in Q3 2019 was Tower Research Capital (TRC), an estimated $10.4K added.
  • The largest iShares Evolved U.S. Innovative Healthcare ETF seller in Q3 2019 was BlackRock, an estimated $1.74M sold.

Based on aggregated 13F filings for Q3 2019.